Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstracts
Cardiovascular, Case Report
Cardiovascular, Commentary
Cardiovascular, Editorial
Cardiovascular, Guest Editorial
Cardiovascular, Images in Cardiology
Cardiovascular, Interventional Round
Cardiovascular, Original Article
Cardiovascular, Perspective Review
Cardiovascular, Preface
Cardiovascular, Review Article
Cardiovascular, Student’s Corner
Case Report
Case Report, Cardiovascular
Case Reports
Case Series, Cardiovascular
Clinical Discussion
Clinical Rounds
CPC
Current Issue
Debate
Dedication
Editorial
Editorial Cardiovascular
Editorial, From the Publisher’s Desk
Expert Comments
Expert's Opinion
Genetic Autopsy
Genetics Autopsy
Guest Editorial, Cardiovascular
Image in Cardiology
Images in Cardiology
Images in Cardiology, Cardiovascular
Interventional Round
Interventional Round, Cardiovascular
Interventional Rounds
Letter to Editor
Letter to the Editor
Media and news
Original Article
Original Article, Cardiovascular
Original Article, Cardiovascular Health
Practice in Medicine
Preface
Review Article
Review Article, Cardiovascular
Scientific Paper
Short Communication
Student's Corner
Supplementary
Supplemetary
WINCARS Activities
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstracts
Cardiovascular, Case Report
Cardiovascular, Commentary
Cardiovascular, Editorial
Cardiovascular, Guest Editorial
Cardiovascular, Images in Cardiology
Cardiovascular, Interventional Round
Cardiovascular, Original Article
Cardiovascular, Perspective Review
Cardiovascular, Preface
Cardiovascular, Review Article
Cardiovascular, Student’s Corner
Case Report
Case Report, Cardiovascular
Case Reports
Case Series, Cardiovascular
Clinical Discussion
Clinical Rounds
CPC
Current Issue
Debate
Dedication
Editorial
Editorial Cardiovascular
Editorial, From the Publisher’s Desk
Expert Comments
Expert's Opinion
Genetic Autopsy
Genetics Autopsy
Guest Editorial, Cardiovascular
Image in Cardiology
Images in Cardiology
Images in Cardiology, Cardiovascular
Interventional Round
Interventional Round, Cardiovascular
Interventional Rounds
Letter to Editor
Letter to the Editor
Media and news
Original Article
Original Article, Cardiovascular
Original Article, Cardiovascular Health
Practice in Medicine
Preface
Review Article
Review Article, Cardiovascular
Scientific Paper
Short Communication
Student's Corner
Supplementary
Supplemetary
WINCARS Activities
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstracts
Cardiovascular, Case Report
Cardiovascular, Commentary
Cardiovascular, Editorial
Cardiovascular, Guest Editorial
Cardiovascular, Images in Cardiology
Cardiovascular, Interventional Round
Cardiovascular, Original Article
Cardiovascular, Perspective Review
Cardiovascular, Preface
Cardiovascular, Review Article
Cardiovascular, Student’s Corner
Case Report
Case Report, Cardiovascular
Case Reports
Case Series, Cardiovascular
Clinical Discussion
Clinical Rounds
CPC
Current Issue
Debate
Dedication
Editorial
Editorial Cardiovascular
Editorial, From the Publisher’s Desk
Expert Comments
Expert's Opinion
Genetic Autopsy
Genetics Autopsy
Guest Editorial, Cardiovascular
Image in Cardiology
Images in Cardiology
Images in Cardiology, Cardiovascular
Interventional Round
Interventional Round, Cardiovascular
Interventional Rounds
Letter to Editor
Letter to the Editor
Media and news
Original Article
Original Article, Cardiovascular
Original Article, Cardiovascular Health
Practice in Medicine
Preface
Review Article
Review Article, Cardiovascular
Scientific Paper
Short Communication
Student's Corner
Supplementary
Supplemetary
WINCARS Activities
View/Download PDF

Translate this page into:

Original Article
Cardiovascular
9 (
1
); 15-21
doi:
10.25259/IJCDW_51_2023

Navigating the Risk: “Unraveling the Relationship between Thrombolysis in Myocardial Infarction (“TIMI” Risk Score) and Coronary Vessel Involvement in Non-ST-Elevated acute Coronary Syndrome with Respect to “Syntax” Score – A Cross-sectional Study”

Department of Cardiology, Alluri Sita Ramaraju Academy of Medical Sciences, Eluru, Andhra Pradesh, India.

*Corresponding author: Iragavarapu Tammiraju, Department of Cardiology, Alluri Sita Ramaraju Academy of Medical Sciences, Eluru, Andhra Pradesh, India. vmrtraju.mbbs@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Tammiraju I, Ramisetty B, Gujjarlapudi AJ. Navigating the Risk: “Unraveling the Relationship between Thrombolysis in Myocardial Infarction (“TIMI” Risk Score) and Coronary Vessel Involvement in Non-ST-Elevated acute Coronary Syndrome with Respect to “Syntax” Score – A Cross-sectional Study.” Indian J Cardiovasc Dis Women. 2024;9:15-21. doi: 10.25259/IJCDW_51_2023

Abstract

Objectives:

Patients with unstable angina and non-ST-elevated myocardial infarction (NSTEMI) present with a spectrum of cardiac events and death. Hence, early accurate management should be initiated. This can be achieved by risk stratifying the patients as early as possible on hospital admission. Thrombolysis in myocardial infarction (TIMI) risk score assessment is used widely for this purpose. It helps to standardize the approach of management and compare the extent and number of vessels involved in the coronary angiogram. This research aims to assess coronary artery disease (CAD) in individuals with NSTEMI by examining the extent of vessel involvement and the complexity of coronary artery blockages, using the SYNTAX score about the TIMI risk score.

Materials and Methods:

This cross-sectional observational study involved 60 participants who were selected based on specific inclusion and exclusion criteria. The TIMI risk score was computed for each individual, categorized as either <4 or ≥4, and the results of their coronary angiogram were analyzed to assess the degree of vessel involvement, categorizing it as either single-vessel disease (SVD) or multi-vessel disease (MVD). The Syntax score was computed for all angiograms and divided into two groups based on whether it was ≤22 or >22.

Results:

The average age of the participants in our study was 56 ± 10.64, with an age range of 34. Gender distribution revealed a higher proportion of males, constituting 68.3% (41 individuals), while females accounted for 31.7% (19 individuals). The angiogram results demonstrated that among the patients with TIMI score <4, 70% (14 individuals) had SVD, 30% (6 individuals) had MVD, and among those with score ≥4, 15% (6 individuals) had SVD while 75% (34 individuals) had MVD. In the subgroup analysis of TIMI <4, a Syntax score <22 was observed in 15 cases of SVD and a score >22 was observed in cases of MVD. Likewise, in the TIMI >4 group, a Syntax score <22 was observed in 12 cases of SVD and a score >22 was observed in 28 cases of MVD.

Conclusion:

This study noted that patients with non-ST-segment elevation acute coronary syndrome who underwent coronary angiogram and had a TIMI score of ≥4 were observed to have a 13-fold increased likelihood of having multi-vessel Coronary artery disease (CAD) compared to those with a TIMI score of <4. TIMI score of ≥4 had a 7 times higher chance of getting a SYNTAX score >22.

Keywords

Non-ST-elevated myocardial infarction
Thrombolysis in myocardial infarction score
Angiography
Single-vessel disease
Multi-vessel disease
SYNTAX score

ABSTRACT IMAGE

INTRODUCTION

Coronary artery disease (CAD) is a major health hazard in both industrialized and developing nations, and it is of great concern due to the high mortality rate that it causes.[1] Acute coronary syndrome (ACS) includes acute myocardial infarction and unstable angina, which together result in approximately 7 million deaths each year.[2] The majority of ACS patients (70%) present with non-ST-elevated myocardial infarction (NSTEMI), for which treatment options are not clear.[3] Despite advances in therapeutic interventions, NSTEMI patients still experience high morbidity and mortality rates. Therefore, it is crucial to assess risk factors early on for prognosis and to initiate treatment during the critical early hours. Several scoring systems have been developed to stratify ACS patients based on their risk. The thrombolysis in myocardial infarction (TIMI) risk score is widely used due to its simplicity, as it involves evaluating seven independent clinical indicators in each patient.[4] The SYNTAX score which incorporates characteristics of lesion complexity, lesion location, and the number of lesions was developed during the SYNTAX trial to classify patients according to the severity of their CAD [Table 1].

Table 1: TIMI UA/NSTEMI risk score.
1 Age≥65 1 point
2 ≥3 risk factors for CAD 1 point
3 Use of ASA (past 7 days) 1 point
4 Known CAD (prior stenosis≥50%) 1 point
5 >1-episode rest angina in<24 h 1 point
6 ST-segment deviation 1 point
7 Elevated cardiac markers 1 point

UA/NSTEMI: Unstable angina non-ST-elevated myocardial infarction, TIMI: Thrombolysis in myocardial infarction, CAD: Coronary artery disease, ASA: Acetyl salicylic acid

MATERIALS AND METHODS

Design and setting

It was a cross-sectional observational survey of 60 patients with non-ST-segment elevation ACS (NSTE-ACS) presented to the cardiology unit of ASRAM Institute. The study was completed in 2 months (March–April 2023).

Sample collection and criteria

All patients with NSTE-ACS under the age group of 30–80 years irrespective of gender were included in the study.

Exclusion criteria

The following criteria were excluded from the study:

  • Hemodynamic instability due to mechanical complications (e.g., acute Mitral regurgitation [MR] and Ventricular septal defect [VSD])

  • Unstable ventricular arrhythmias

  • Congenital heart disease

  • Prior percutaneous transluminal coronary angioplasty/coronary artery bypass grafting

  • Myocarditis/pericarditis.

All patients were tested for cardiac enzymes by immunometric assay.

Data collection methods

After obtaining proper consent, a thorough history was taken and an examination was done on the patients. Risk factors including diabetics, hypertension, dyslipidemia, and family H/o of CAD were noted. Electrocardiogram (ECG) and echocardiography were done according to standard protocols. All the data were recorded on a short structured questionnaire. TIMI risk score was calculated for each patient. All patients were categorized into TIMI scores of <4 and ≥4. Patients were further evaluated with coronary angiograms to assess CAD. All the angiograms were performed by a single physician. Vessels with >70% were considered to have significant disease in our study. The online latest version was used for the calculation of the Syntax score (http://www.SYNTAXscore.com). The coronary artery lesions were divided into two groups: those with a SYNTAX score of 22 or lower, representing lesions of low to moderate complexity, and those with a score above 22, indicating higher complexity of lesions.

Statistical technique

Both descriptive and inferential statistical analysis was done in a Statistical Package of the Social Sciences version trail version 26.0. Data were presented in the form of frequencies and percentages; categorical data were analyzed using the Chi-square test. P ≤ 0.05 was considered statistically significant.

RESULTS

A total of 60 patients having NSTE-ACS presenting to the cardiac department in our Institute were studied. There was a male predominance of 68.3%, male–to-female ratio was 2.1:1, and the mean age of study was 56 years. Among risk factors recurrent episodes of angina (98.7%), elevated cardiac enzymes (75%), and prior documented CAD (63.3%) were common in our study.

The demographic profile is mentioned in Table 2.

Table 2: Demographic features of the study patients.
Age in years (mean±SD) 56±10.64
Age in range 74–40
Males 41 (68.3%)
Females 19 (31.7%)
Hypertension 37 (61.7%)
Diabetes mellitus 36 (60%)
Dyslipidemia 42 (70%)
Smoker 22 (36.7%)
Family history of CAD 1 (1.7%)

SD: Standard deviation, CAD: Coronary artery disease

The percentage of each TIMI risk factor for all cases in our study is shown in Table 3.

Table 3: TIMI risk score n (%).
Age>65 years 13 (21.7%)
>3 risk factors of CAD 27 (45%)
Prior documented CAD>50% stenosis 38 (63.3%)
ST deviation>0.5 mm 23 (38.3%)
>2 episodes of angina within the past 24 h 58 (98.7%)
ASA usage within the prior week 34 (56.7%)
Elevated cardiac enzymes 45 (75%)

TIMI: Thrombolysis in myocardial infarction, CAD: Coronary artery disease, ASA: Acetyl salicylic acid

Table 4 illustrates the distribution of TIMI scores, coronary vessel involvement, and SYNTAX scores in male and female subsets of the population.

Table 4: Distribution of TIMI scores, coronary vessel involvement, and SYNTAX scores in male and female subsets of the population.
Total n=60 Males (41) Females (19)
TIMI
  <4 19 (46.3%) 13 (68.4%)
  ≥4 22 (53.7%) 6 (31.6%)
Coronary vessel involvement
  SVD 12 (29.3%) 10 (52.6%)
  MVD 29 (70.7%) 9 (47.4%)
SYNTAX
  <22 11 (26.8%) 8 (42.10%)
  >22 30 (73.17%) 11 (57.89%)

SVD: Single-vessel disease, TVD: Triple-vessel disease, MVD: Multi-vessel disease, TIMI: Thrombolysis in myocardial infarction, SYNTAX: Synergy between percutaneous intervention with taxus and coronary artery bypass surgery

In this study, it was noted that among males, there was a higher prevalence of TIMI scores ≥4, multivessel disease (MVD), and SYNTAX scores >22. In females, TIMI scores <4 and single-vessel disease (SVD) were slightly more common, while SYNTAX exceeding 22 was observed to be higher in both men and women, with a somewhat higher proportion in men.

Table 5 shows that 14 patients (70%) had SVD, 6 patients (30%) had MVD with a TIMI score <4, 6 patients (15%) had SVD, and 34 patients (75%) had MVD with TIMI risk score of ≥4. TIMI risk score is significantly associated with several vessels in CAD (P < 0.001). TIMI score of ≥4 had a 13 times higher chance of getting multivessel CAD compared to patients with a TIMI score of <4. (Crudes Odds ratio: 13.22; 95% confidence interval: 3.6343–48.1047; P = 0.0001).

Table 5: TIMI risk scores and angiographic disease correlation.
Number of vessels Chi-square value P-value
SVD MVD (DVD+TVD)
TIMI score
  TIMI score<4 14 (70%) 6 (30%) 18.15 <0.001
  TIMI score≥4 6 (15%) 34 (85%)

TIMI: Thrombolysis in myocardial infarction, SVD: Single-vessel disease, DVD: Double-vessel disease, TVD: Triple-vessel disease, MVD: Multi-vessel disease

Table 6 shows in the subgroup analysis of TIMI <4, a SYNTAX score <22 was observed in 13 cases of SVD and two cases of MVD, and a score >22 was observed in single case of SVD and four cases of MVD. Likewise, in the TIMI ≥4 group, a SYNTAX score <22 was observed in two cases of SVD and ten cases of MVD, and a score >22 was observed in four cases of SVD and 24 cases of MVD. TIMI risk score is significantly associated with SYNTAX score. TIMI score of ≥4 had a 7 times higher chance of getting a SYNTAX score of >22.

Table 6: The relationship between the TIMI score and the SYNTAX score with respect to Coronary vessel involvement.
TIMI score<4 TIMI score≥4 Chi-square value P-value
SVD MVD (DVD+TVD) SVD MVD
SYNTAX score
SYNTAX score<22 13 2 2 10 10.9091 <0.001
SYNTAX score>22 1 4 4 24

SYNTAX: Synergy between percutaneous intervention with taxus and coronary artery bypass surgery, TIMI: Thrombolysis in myocardial infarction, SVD: Single-vessel disease, DVD: Double-vessel disease, TVD: Triple-vessel disease, MVD: Multi-vessel disease

DISCUSSION

As per the World Health Organization, cardiovascular disease is expected to become the leading cause of death in developing nations.[5] Despite therapeutic advances, CAD remains the leading cause of death worldwide.[6] Knowing the low survival rate in high-risk patients, giving the right and early treatment becomes important. As NSTEMI patients are more prone to cardiac complications, early risk stratification plays the main role in the optimal management of the NSTE-ACS group.[7] Guidelines from the American Heart Association, American College of Cardiology, and European Society of Cardiology recommend that suitable pharmacotherapy and early therapeutic interventions would decrease the adverse outcomes in high-risk patients of NSTEACS.[7,8] A new study has found that in NSTE-ACS patients, cardiac catheterizations are not being performed optimally due to less or no correct knowledge about risk assessment.[9] To overcome this problem, different risk assessment scores have been developed but only a few have been put forward. Thrombolysis in myocardial infarction (TIMI), Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT), and global registry of acute coronary events (GRACE) scores have established their roles in risk stratification and predicting prognosis (5.6).[10-14] Out of these, the “TIMI risk score” system is widely used due to its simplicity and its bedside easy assessing ability. TIMI risk score is an effective risk assessment tool for in-hospital mortality and 14-day mortality among NSTEMI patients. Various studies have validated its use.[15-17] It is effective in both chronic (6-month) and acute (14-day) presentations of patients with chest pain.[18-20] When originally developed, the TIMI risk score was correlated by Antman et al.[4] with clinical endpoints of non-ST-elevation ACS, such as death and myocardial infarction. The use of the TIMI score for NSTEACS was validated by TACTICS-TIMI.[21]

It is beneficial to predict the angiographic assessment of CAD using one of the proven risk-scoring systems, as it has a predictive value for Major Adverse Cardiovascular Events (MACE). A Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) analysis showed that the frequency of high-risk angiographic findings, such as severe (>70%) culprit stenosis, MVD, visible thrombus, and left main disease, increased gradually as TIMI risk scores ranged from low to high.[22] This also indirectly indicates that as the TIMI risk score rises, the complexity of CAD also increases. Hence, we have evaluated the SYNTAX score, which assesses the angiographic severity and complexity of CAD about the TIMI score.

On analyzing individual variables within the TIMI score in our study, we observed that the majority of patients (98.7%) experienced multiple episodes (more than 2) of angina within the past 24 h, and 75% of patients exhibited elevated cardiac enzymes on presentation with CAD, irrespective of the presentation type. Elevated cardiac enzymes have consistently demonstrated heightened sensitivity in predicting mortality in various studies. Khandelwal et al.[23] reported similar findings in their study. In addition, Van Miltenburg-van Zijl et al.[24] have highlighted the significance of the variable “Severity of angina” about a poor prognosis. Some studies have shown the superiority of GRACE over TIMI in predicting the extent of CAD, but many other studies have shown that they both were equally good in the correlation to high-risk CAD in angiography.[25]

In our study, men exhibited higher TIMI scores and a greater prevalence of MVD compared to females. In addition, our study revealed that patients with a TIMI score of ≥4 had a 13 times higher likelihood of developing multi-vessel CAD compared to those with a TIMI score of <4. Similar findings of the correlation of high TIMI scores with MVD were reported by some previous research also.[26] In their study, Garcia et al.[27] and Mega et al.[22] found that when using a TIMI score cutoff of >5, there was a higher prevalence of MVD and left main disease compared to cases with lower scores. Similarly, another study conducted by Abbas et al.[28] showed that even a TIMI score cutoff of 4 could distinguish a greater extent of disease. A study done by Bashiruddin et al.,[29] showed a positive correlation between the Gensini score (Severity of Angiographic disease) and TIMI score. Recently, Parikh et al.,[30] have shown that TIMI risk scores predict severe coronary atherosclerosis in patients with end-stage renal disease.

In our study, a TIMI score of ≥4 had a 7 times higher chance of getting a SYNTAX score of >22 indicating more complexity of angiographic disease in patients with high TIMI score. There have not been many studies comparing the TIMI and SYNTAX scores, and our study is one of those rare studies that have explored this relationship.[31]

Various studies done on the comparison of TIMI scores and CAD are shown in Table 7.[22,23,25-29,32,33]

Table 7: The results of various studies done on the comparison of TIMI scores and CAD.
S. No. Study Year Conclusion
1. Garcia et al.[27] 2004 High TIMI correlated with severe CAD and left main CAD
2. Ben et al.[26] 2011 TIMI (0–2) No significant CAD, TIMI (5–7) critical TVD LM disease
3. Mega et al.[22] 2011 TIMI score (5–7) more severe MVD
4. Bashiruddin et al.[29] 2019 TIMI score significantly correlated with Gensini CAD score in NSTEMI
5. Roy et al.[25] 2018 GRACE and TIMI are good predictive valves in the assessment of the severity of CAD in NSTEMI
6. Khandelwal et al.[23] 2015 GRACE and PURSUIT scores had more correlation than TIMI
7. Namazi et al.[32] 2022 Direct correlation of TIMI and CAD
8. Hussein and Sabah [33] 2022 Moderate TIMI risk score was associated with double vessel disease
9. Abbas et al.[28] 2020 TIMI score>4 greater extent of CAD
10. Our study 2023 Patients with a TIMI score of ≥4 had a thirteen times more severe Multi vessel disease (MVD) and seven times higher chance of having a Syntax score >22

CAD: Coronary artery disease, LM: Left main disease, NSTEMI: Non-ST elevation MI, TVD: Triple-vessel disease, TIMI: Thrombolysis in myocardial infarction, MVD: Multi-vessel disease, GRACE: Global registry of acute coronary events, PURSUIT: Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy, SYNTAX: Synergy between PCI with taxus and cardiac surgery

Limitations

The small study population is a major limitation of our study; larger cohorts with multiple centers are needed to further validate the results. Our study has focused only on angiographic severity but not the overall outcome of the patients which is a better marker of prognosis. Angiographic assessment is done by “eyeball” estimation rather than intravascular ultrasound (IVUS)/fractional flow reserve (FFR) methods which are more validated tools for quantitative and quantitative assessment of CAD. The SYNTAX scoring system may be susceptible to subjective errors, but these errors can be minimized by involving multiple assessors in the scoring process.

CONCLUSION

The TIMI score can serve as a predictor for both the presence and extent of CAD observed during angiography. For patients experiencing NSTE-ACS and having a TIMI score of 4 or higher, an early invasive approach involving coronary angiography and revascularization should be considered as the preferred management strategy. In a developing country like ours, this study helps us to prioritize the limited resources for early interventions in high-risk TIMI scores for decreasing mortality and better patient care.

Ethical approval

The Institutional Review Board approval is not required.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Audio summary available at

https://doi.org/10.25259/IJCDW_51_2023

Financial support and sponsorship

Nil.

References

  1. , . Emerging Epidemic of Cardiovascular Disease in Developing Countries. Circulation. 1998;97:596-601.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , . Global Perspective on Acute Coronary Syndrome: A Burden on the Young and Poor. Circ Res. 2014;114:1959-75.
    [CrossRef] [PubMed] [Google Scholar]
  3. . Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock. Cardiol Rev. 2018;26:255-66.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , , et al. The TIMI Risk Score for Unstable Angina/non-ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making. JAMA. 2000;284:835-42.
    [CrossRef] [PubMed] [Google Scholar]
  5. , . Cardiac Arrest and Sudden Cardiac Death In: , , , , eds. Braunwald's Heart Disease (8th ed). Philadelphia, PA: Saunders Elsevier; . p. :933-74.
    [Google Scholar]
  6. , . Mortality by Cause for Eight Regions of the World: Global Burden of Disease Study. Lancet. 1997;349:1269-76.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , , , , et al. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2007;50:e1-157.
    [CrossRef] [Google Scholar]
  8. , , , , , , et al. ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with Acute Myocardial Infarction) J Am Coll Cardiol. 2004;44:e1-211.
    [Google Scholar]
  9. , , , , , , et al. Management of ACS in Patients Presenting without Persistent ST-Segment Elevation. Eur Heart J. 2007;28:1598-660.
    [Google Scholar]
  10. , , , , , , et al. Use of Cardiac Catheterization for Non-ST-segment Elevation Acute Coronary Syndromes According to Initial Risk: Reasons why Physicians Choose not to Refer their Patients. Arch Intern Med. 2008;168:291-6.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , , , et al. Risk Stratification in Unstable Angina. Prospective Validation of the Braunwald Classification. JAMA. 1995;273:136-41.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. PREDICT: A Simple Risk Score for Clinical Severity and Long-Term Prognosis After Hospitalization for Acute Myocardial Infarction or Unstable Angina: The Minnesota Heart Survey. Circulation. 1999;100:599-607.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. Predictors of Outcome in Patients with Acute Coronary Syndromes without Persistent ST-Segment Elevation. Results from an International Trial of 9461 Patients. The PURSUIT Investigators. Circulation. 2000;101:2557-67.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2003;163:2345-53.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , . Application of the TIMI Risk Score for Unstable Angina and non-ST Elevation Acute Coronary Syndrome to an Unselected Emergency Department Chest Pain Population. Acad Emerg Med. 2006;13:13-8.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , , , . Prospective Validation of the Thrombolysis in Myocardial Infarction Risk Score in the Emergency Department Chest Pain Population. Ann Emerg Med. 2006;48:252-9.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Unstable Angina Pectoris and non-ST-Elevation Myocardial Infarction in the TIMI III Registry. Am J Cardiol. 2002;90:303-5.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , . Cardiac Troponin I am Associated with Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure. Circulation. 2003;108:833-8.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , , , et al. Timing of Angiography and Revascularization in Acute Coronary Syndromes: An Analysis of the TACTICS-TIMI-18 Trial. J Interv Cardiol. 2004;17:81-6.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. One-year Results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized Comparison of Tissue-type Plasminogen Activator Versus Placebo and Early Invasive Versus Early Conservative Strategies in Unstable Angina and non-Q Wave Myocardial Infarction. J Am Coll Cardiol. 1995;26:1643-50.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , . Universal Definition of Myocardial Infarction Ration. Pharmacother Cardiol. 2016;4:91-105.
    [CrossRef] [Google Scholar]
  22. , , , , , , et al. Correlation between the TIMI Risk Score and High-risk Angiographic Findings in non-ST-Elevation Acute Coronary Syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial. Am Heart J. 2005;149:846-50.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , . Prediction of Angiographic Extent of Coronary Artery Disease on the Basis of Clinical Risk Scores in Patients of Unstable Angina. J Clin Diagn Res. 2015;9:C13-6.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , . Incidence and follow-up of Braunwald Subgroups in Unstable Angina Pectoris. J Am Coll Cardiol. 1995;25:1286-92.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , . GRACE and TIMI Risk Scores in Predicting the Angiographic Severity of non-ST Elevation Acute Coronary Syndrome. Indian Hea rt J. 2018;70(Suppl 3):S250-3.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Correlation of TIMI Risk Score with Angiographic Extent and Severity of Coronary Artery Disease in non-ST-Elevation Acute Coronary Syndromes. Ann Cardiol Angéiol (Paris). 2011;60:87-91.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Correlation of TIMI Risk Score with Angiographic Severity and Extent of Coronary Artery Disease in Patients with non-ST-Elevation Acute Coronary Syndromes. Am J Cardiol. 2004;93:813-6.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , , , , et al. Association of Thrombolysis in Myocardial, Infarction (TIMI) Risk Score with Extent of Coronary Artery Disease in Patients with Unstable Angina and NSTEMI. Pakistan Armed Forces Med J. 2020;70:S787-91.
    [CrossRef] [Google Scholar]
  29. , , , , , , et al. Association of Thrombolysis in Myocardial Infarction (TIMI) Risk Score with Angiographic Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome. Univ Heart J. 2019;15:68-73.
    [CrossRef] [Google Scholar]
  30. , , , . HEART and TIMI Scores Predict Severe Coronary Atherosclerosis in Patients with End-Stage Renal Disease. Cureus. 2023;15:e40408.
    [CrossRef] [Google Scholar]
  31. , , , , , , et al. Comparison of SYNTAX Score II Efficacy with SYNTAX Score and TIMI Risk Score for Predicting in-Hospital and Long-term Mortality in Patients with ST-Segment Elevation Myocardial Infarction. Int J Cardiovasc Imaging. 2018;34:1165-75.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , . Correlation Between TIMI Risk Score and the Number of Vessels Involved in the Angiographic Study; a Cross-Sectional Study. Arch Acad Emerg Med. 2022;10:e16.
    [Google Scholar]
  33. , . The Prediction Role of TIMI Score in Correlation with Coronary Angiogram to Determine the Coronary Artery Disease Severity and Extent in Patients Presenting with Non-ST Elevation Acute Coronary Syndrome. Diyala J Med. 2022;22:29-44.
    [CrossRef] [Google Scholar]
Show Sections